Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (2R)-5-(2-chlorophenyl)sulfanyl-4-hydroxy-2-(4-morpholin-4-ylphenyl)-2-thiophen-3-yl-1,3-dihydrop... | 2003234-63-5 | MFCD31560470 | 99.8% | 499.04 | C25H23ClN2O3S2 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY100742A50MG

Encompass_Preferred

(R)-GNE-140 is the R-enantiomer of a potent lactate dehydrogenase A (LDHA) inhibitor used in biochemical and cellular research to probe LDH function and cancer metabolism. It exhibits nanomolar inhibition of LDHA and LDHB and has characterized purity, solubility, and storage properties suitable for in vitro and in vivo studies.

  • Nanomolar inhibition of LDHA and LDHB (IC50 3 nM and 5 nM).
  • R enantiomer is ~18-fold more potent than the S enantiomer.
  • High chemical purity (99.77%) with enantiomeric excess ~99.14%.
  • Solid, off-white to yellow appearance.
  • Soluble in DMSO ≥ 50 mg/mL for in vitro use.
  • Formulation suitable for in vivo dosing (≥ 2.5 mg/mL in 10% DMSO/40% PEG300/5% Tween-80/45% saline).
  • Storage: powder at -20°C (stable for years) or 4°C for shorter term; in solvent store at -80°C or -20°C depending on duration.

Catalog No. 50-002-11918


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.